Enjuvia
Generic Name:
Estrogen
Brand Names:
Cenestin, Enjuvia, Estrace, Femtrace, Gynodiol, Menest, Ogen, Premarin
Enjuvia Description:
Enjuvia is the trade name for a medication of estrogen hormones marketed by Duramed. the time of menopause, which marks the end of monthly menstruation, a woman's estrogen levels drop significantly, which may result in various physical and emotional discomforts. Estrogen supplements such as Enjuvia are prescribed to avoid certain symptoms of menopause including hot flashes. Different types of estrogen are prescribed depending upon the age of the patient and her complaints.
Enjuvia Uses:
At or around the time of menopause women may experience discomforts such as hot flashes. Hot flashes are characterized by a sudden sense of heat with sweating while chills may occur causing a woman to feel very cold (with or without dizziness). These symptoms surface due to the sudden drop of estrogen levels in women experiencing menopause. Enjuvia can help counteract some of the discomforts of menopause.
In some cases, Enjuvia is prescribed to prevent osteoporosis in women after menopause. Though it may also be prescribed to treat vaginal dryness, it is not recommended as there are substitutes available with fewer side effects.
Estrogen is generally not prescribed to only prevent osteoporosis or to solely treat vaginal itching, drying or burning, because there are other medications that have fewer side effects than estrogen medications.
Enjuvia may also be prescribed to women whose body does not produce adequate amounts of estrogen.
Women may experience mood swings or low temperament before menstruation or at the time of menopause. Enjuvia may also be prescribed to such women if the doctor is sure that their low moods are due to low levels of estrogen.
Enjuvia Interactions:
These drugs may alter the effect or may negatively interact with Enjuvia and should be avoided when using the medication:
- Amiodarone
- Aprepitant
- Atazanavir
- Carbamazepine
- Cimetidine
- Clarithromycin
- Cyclosporine
- Delavirdine
- Dexamethasone
- Diltiazem
- Efavirenz
- Erythromycin
- Fluoxetine
- Fluvoxamine
- Griseofulvin
- Indinavir
- Itraconazole
- Ketoconazole
- Lopinavir
- Lovastatin
- Medications for Thyroid Disease
- Nefazodone
- Nelfinavir
- Nevirapine
- Phenobarbital
- Phenytoin
- Rifabutin
- Rifampin
- Ritonavir
- Saquinavir
- Sertraline
- Troleandomycin
- Verapamil
- Zafirlukast
Enjuvia Dosage Information:
Typical Dosage Recommendations
Recommended dosage for Enjuvia differs according to the age of the patient and the condition the medication is intended to treat, though a typical dose does not generally exceed 30mg per day. The amount of estrogen that must be taken daily and the time the medication should be taken must be prescribed only by the doctor.
For treatment of breast cancer in women after menopause, the recommended dosage of Enjuvia is 10 mg of estrogen, three times a day for at least three months.
For treatment and prevention of osteoporosis in women after menopause, the recommended dosage of Enjuvia is 0.3mg of estrogen per day.
Missing a Dose
Enjuvia should ideally be taken at the same time every day. If a dose is missed, take it as soon as you remember. If it is almost time for the next dose, skip the missed and continue your regular dosing pattern. Never take a double dose as it may increase the chances for unwanted side effects.
Overdosing
Never take a higher dose of Enjuvia than prescribed and never double dose. Overdosing of Enjuvia may result in serious complications. The symptoms of overdose of Enjuvia are an upset stomach, nausea or vomiting with vaginal bleeding similar to a monthly period. Seek medical attention following an overdose of Enjuvia.
Enjuvia FDA Approval:
May 10, 2004
Enjuvia Recall/Black Box Warning Information:
There are no recalls for Enjuvia.
Endometrial Cancer Risk
Enjuvia carries a Black Box Warning for an increased risk of endometrial cancer among those who intake estrogen. The risk of developing the cancer is approximately two to twelve times greater than those who do not use estrogen. The greatest risk seems to be linked with prolonged usage of estrogen.
Cardiovascular and Other Risks
Enjuvia carries a Black Box Warning concerning a large study that found that women who took estrogen with progestins had a higher risk of heart attacks, strokes, blood clots in the lungs or legs, breast cancer, and dementia. The study also found that women who take estrogen alone may also have a higher risk of developing these conditions.
Other Warnings
Estrogen must never be taken by patients who have a history of heart attack, stroke, blood clots and/or breast cancer. Patients who have experienced high levels of blood pressure or fat or cholesterol levels should notify a doctor as such conditions may worsen after the intake of estrogen.
Estrogen is almost never prescribed to children especially girls before puberty as it may induce early menstruation and may stop growth in bones.
As breast cancer may be caused by the high levels of estrogen intake, women are advised to receive a mammogram every year to detect cancer at an early stage following menopause.
-
July 30, 2010, 2:23 pm
-
July 30, 2010, 2:13 pm
-
July 29, 2010, 12:33 pm
-
July 28, 2010, 3:58 pm
